Metadata
- Name
- HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT02485938
- Description
- Male subjects with cardiomyopathy secondary to Duchenne muscular dystrophy (DMD) meeting all
inclusion and no exclusion criteria will be randomized. All subjects will be at least 12
years of age. They will be randomized in a 1:1 manner to either intracoronary infusion of
CAP-1002 in three coronary arteries supplying the three major cardiac territories of the left
ventricle of the heart (anterior, lateral, inferior/posterior) or usual care. In the active
treatment arm, all three major cardiac territories will be treated (infused) during a single
procedure in an open-label fashion. - Data or Study Types
- clinical trial
- Keywords
- Duchenne Muscular Dystrophy, Cardiomyopathy
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2015
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT02485938
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT02485938